THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION
Atrial fibrillation (AF) is one of the most common cardiac rhythm disorders. Its prevalence is about 1 % in the general population and exceeds 7 % in individuals older than 60 years of age. It is known that hyperactivation of the renin-angiotensin-aldosterone system plays a key role in structural an...
Saved in:
Main Authors: | N. T. Vatutin (Author), A. N. Shevelok (Author), G. G. Taradin (Author), I. N. Kravchenko (Author) |
---|---|
Format: | Book |
Published: |
SINAPS LLC,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of aldosterone in the development of atrial fibrillation: modern understanding of problem
by: N. T. Vatutin, et al.
Published: (2019) -
Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Daiji Kawanami, et al.
Published: (2021) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021) -
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
by: Funder JW
Published: (2013)